China Resources Pharmaceutical Group Limited

HKEX:3320.HK

4.96 (HKD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q4
Operating Activities:
Net Income 2,822.631,206.3723,038.061,122.3663,025.0461,330.7832,438.106719.9322,577.194251.0493,035.371,727.9762,249.6271,672.5891,810.4471,185.3411,636.069568.4122,281.664712.519661.485661.485661.485661.485659.879659.879659.879659.879
Depreciation & Amortization 1,764.1611,767.9291,715.6951,549.3351,602.8151,456.8691,365.0211,240.6321,203.4211,240.2621,124.585739.417777.986663.036788.679507.598675.311677.941589.529336.462338.201338.201338.201338.201298.924298.924298.924298.924
Deferred Income Tax 00-16,295.9746,097.982-13,813.5633,443.3520000000000000000000000
Stock Based Compensation 075.24980.963101.78501.4340000000000000000000000
Change In Working Capital 013,722.868-13,283.1889,973.623-10,908.4218,299.831-7,999.5132,647.567-6,410.0647,715.428-9,727.2614,689.306-8,030.4992,885.06-8,145.567-6,975.535-6,267.5031,077.302-7,453.691-553.15-909.722-909.722-909.722-909.722-924.743-924.743-924.743-924.743
Accounts Receivables 012,482.797-19,352.7577,428.82-15,451.566,658.26-11,855.891-1,572.237-3,548.4594,823.812-12,410.7543,442.343-6,813.022,285.668-6,799.921-3,364.083-5,372.4381,837.557-8,056.346000000000
Change In Inventory 01,511.282-4,452.823-1,854.458-781.198-945.874-2,464.8381,487.925-2,293.472356.929-894.4031,246.963-1,217.479599.392-1,345.646-3,611.452-895.065-760.255602.655-39.4-945.884-945.884-945.884-945.884-273.751-273.751-273.751-273.751
Change In Accounts Payables 0011,021.9593,727.6225,635.695646.1386,890.412,876.621-1,335.5952,358.7393,830.86000000-88.172513.75000000000
Other Working Capital 0-271.212-499.567671.639-311.3581,941.307-569.194-144.742767.462175.948-252.96400000000-513.7536.16136.16136.16136.161-650.991-650.991-650.991-650.991
Other Non Cash Items 46.7194,615.85119,245.693-3,581.41215,714.741-1,218.63312,263.5472,028.92411,542.893-4,104.10412,383.2394,439.941,653.2124,513.989669.3058,790.6714,567.6953,159.8835,087.751,001.367956.717956.717956.717956.717991.478991.478991.478991.478
Operating Cash Flow 1,105.18821,388.269-5,498.75115,267.226-4,368.51213,313.636-2,093.26,948.1-670.92410,161.591-4,907.53411,596.639-3,349.6749,734.674-4,877.1363,508.075611.5725,483.538505.2521,497.1981,046.6811,046.6811,046.6811,046.6811,025.5391,025.5391,025.5391,025.539
Investing Activities:
Investments In Property Plant And Equipment 0-1,499.152-1,417.324-1,727.013-1,629.312-1,958.011-944.856-1,431.071-787.428-1,219.803-820.709-635.262-881.384-408.305-1,158.407-1,053.257-665.177-1,391.77-431.419-9.97-0.597-0.597-0.597-0.5972.3242.3242.3242.324
Acquisitions Net 0-1,035.51,402.475-1,369.215797.059-930.079-81.001-227.001144.047-251.3381,286.283000000-707.837186.245000000000
Purchases Of Investments 00-8,986.88512,914.815-15,962.36612,175.693-13,269.46325,865.285-26,236.73320,729.771-22,332.871000000-3,878.251-4,156.51-4,156.51-3,764.587-3,764.587-3,764.587-3,764.587-1,080.356-1,080.356-1,080.356-1,080.356
Sales Maturities Of Investments 0010,826.071-15,349.25515,365.589-11,802.57511,802.912-22,727.79823,264.24-22,416.3522,546.5760000004,586.0883,970.2653,970.2652,737.3932,737.3932,737.3932,737.393731.293731.293731.293731.293
Other Investing Activites 0-44.55553.7253,610.93850.374-3,840.49915.209104.21710.5613,506.73813.522-7,186.061-1,098.295-3,976.329-2,968.526-472.879238.253-5,146.4582,528.833196.2151,027.7911,027.7911,027.7911,027.791346.74346.74346.74346.74
Investing Cash Flow 3,749.88-2,579.2071,878.062-1,919.73-1,378.656-6,355.471-2,477.1991,583.632-3,605.313349.018692.801-7,821.323-1,979.679-4,384.634-4,126.933-1,526.136-426.924-5,830.3911,911.169-327.292-1,086.092-1,086.092-1,086.092-1,086.092150.769150.769150.769150.769
Financing Activities:
Debt Repayment 00-14,638.136-14,060.066-9,004.46-4,690.207-12,345.924-9,994.176-6,598.193-22,932.03-3,339.950-40,420.9250-20,231.8250-18,355.642-11,301.934-22,907.85-11,328.605-9,563.231-9,563.231-9,563.231-9,563.231-6,937.528-6,937.528-6,937.528-6,937.528
Common Stock Issued 0003,358.440-370.90102,820.720000000003,765.3120000001,320.5041,320.5041,320.5041,320.504
Common Stock Repurchased 000-150.705-332.739-86.761020.941-166.3760000000000000000000
Dividends Paid 0-968.0810-942.3770-0-753.902-691.0760-0-816.986-0.011-691.286-0.009-565.5970000000000000
Other Financing Activities 0-15,100.056-1,523.393-4,556.022-698.84-661.115-149.786-1,488.004-384.62512,130.418-170.6521,731.44844,048.217-5,759.8129,684.1121,902.03715,828.1478,424.62220,465.56711,328.6059,563.2319,563.2319,563.2319,563.2315,617.0245,617.0245,617.0245,617.024
Financing Cash Flow 2,292.84-16,068.13612,747.542-16,688.5457,686.944-5,808.98411,122.076-9,331.5955,730.41-11,455.5662,352.3121,731.4372,936.006-5,759.8198,886.691,902.037-2,527.495888-2,442.283-11,596.661-9,621.278-9,621.278-9,621.278-9,621.278-5,897.391-5,897.391-5,897.391-5,897.391
Other Information:
Effect Of Forex Changes On Cash 0750.6-741.002840.431-803.426-625.698263.009-1,133.489279.682-223.362-4.712-530.945-120.858283.272446.368-406.309-377.514-1,048.51912.23610,296.5069,300.8299,300.8299,300.8299,300.8295,341.5245,341.5245,341.5245,341.524
Net Change In Cash -2,311.3193,491.5268,276.253-1,839.865630.1671,162.7916,441.547-544.6881,129.488-1,056.072-1,867.1334,975.808-2,514.205-126.507328.9893,477.667-2,720.361-10,229.25510,288.332-130.25-359.861-359.861-359.861-359.861620.441620.441620.441620.441
Cash At End Of Period 30,083.00127,423.18432,394.3224,118.06725,957.93225,327.76524,164.97417,723.42718,268.11517,138.62718,194.69916,636.33711,660.52914,174.73414,301.24113,972.25210,494.5853,493.06313,722.3183,303.7373,433.9863,433.9863,433.9863,433.9863,793.8473,793.8473,793.8473,793.847